If you are new to dermatology, it’s hard to imagine that psoriasis was once a difficult problem to manage. The advancements of the past 20 years, including new treatments, have made the disease dramatically easier to control and completely changed the landscape of psoriasis management.
One thing that has not changed in that time: The National Psoriasis Foundation (NPF) remains one of the best resources for education, research, and ensuring patient access to these incredible new treatments. The NPF’s role is as vital as ever, because despite the progress that has been made, new issues related to managing psoriasis are always emerging. In this supplement, for instance, we discuss the challenges of treating psoriatic disease in patients who have HIV, on page 16.
The past two decades of research have also made us more aware of the many comorbidities associated with psoriasis, particularly cardiovascular risk. Dermatologists play an important role in addressing these comorbidities, most importantly through screening. You can read more about that beginning on page 17.
The issue also touches on special sites of psoriasis, specifically including palm/sole, which can be highly resistant to topical treatments because medicines just won’t penetrate, beginning on page 23. And of course the NPF writes about its collaboration on an exciting new real-world trial evaluating the safety and effectiveness of home vs office phototherapy, starting on page 14. They’re even looking for dermatology practices who can volunteer to act as clinical sites—so you have an opportunity to be a part of the next few decades of progress.
Steven R. Feldman, MD, PhD
Chief Medical Editor
Dr Feldman is with the Center for Dermatology Research and the Departments of Dermatology, Pathology, and Public Health Sciences at Wake Forest University School of Medicine in Winston-Salem, NC.